.png)
.png)
NHS England has directed all clustered Integrated Care Boards to formally merge into single entities, with a firm deadline of April 2027. The instruction applies to ICBs that currently operate in a clustered arrangement, sharing executive leadership and administrative functions while remaining distinct legal bodies. That arrangement is now to end, regardless of whether the resulting boundaries align with emerging plans for regional government across England.
The clustered model was introduced as an interim measure following the creation of ICBs under the 2022 Health and Care Act. Under it, boards in geographically proximate areas came to share chief executives, finance directors and other senior roles, reducing duplication without requiring formal structural change. NHS England has now concluded that this approach has run its course. The April 2027 deadline gives affected organisations roughly eighteen months to complete the legal and operational work required to become single statutory bodies.
The speed of the timetable is deliberate. NHS England is not waiting for the outcome of wider debates about English devolution or the redrawing of regional and local government boundaries before pressing ahead with health service consolidation. Senior officials have acknowledged this directly, noting that the new ICB footprints may not correspond to whatever regional government structures eventually emerge. That acknowledgement is significant. It signals that NHS England regards administrative rationalisation within the health system as a priority that cannot be deferred while political processes elsewhere remain unresolved.
The risk this creates is practical rather than theoretical. If regional government boundaries are redrawn in ways that differ materially from the merged ICB footprints, there will be renewed pressure to realign health structures accordingly. Merging now may therefore prove to be an intermediate step rather than a settled outcome. NHS England has accepted this possibility, judging that the efficiency gains from consolidation outweigh the cost of potential boundary mismatches later. Critics of the approach may argue that the sequencing is poor and that a short deferral would have allowed the health system to align with whatever regional governance model Parliament eventually endorses. The clustered model's ongoing operational and financial strain will be cited by supporters.
The stated rationale for the mergers is straightforward. Bringing clustered boards into single entities is expected to reduce duplicated management costs, simplify governance arrangements and create health economies with greater capacity to plan and commission services at scale. Under the current clustered model, boards retain separate governance structures, statutory duties and accountability relationships with NHS England even where their executive teams are shared. Full merger removes those parallel structures. Decision-making sits in a single board, with a single leadership team and a unified financial position.
For ICB leadership teams, the immediate task is to begin the preparatory work that formal merger requires. That includes agreeing a combined constitution, consolidating financial accounts, rationalising staffing structures and engaging with NHS England on the statutory process for dissolving the existing entities and establishing the successor body. One should not undervalue the scope of the job. NHS structural mergers in the past have always taken longer and cost more than anticipated. Although the April 2027 target is set in stone, the participating groups must act swiftly to make it realistic.
What the directive does not resolve is the broader question of how NHS structures will relate to a regional government landscape that remains undefined. That question will return. For now, NHS England has chosen to act within its own sphere rather than wait for answers that may not arrive within any useful timeframe.